Rocket Lab USA (RKLB)

The only US public small-lift operator with a credible medium-lift roadmap — Neutron H2 2026 debut is the binary that re-rates the equity, or doesn't.

Investment Research · Photoncap-style deep dive · Bucket B · 2026-05-22

What Rocket Lab physically does

Rocket Lab is a vertically-integrated space prime running two co-dependent product lines. The first is launch services: the Electron small-lift rocket (200-300 kg to LEO, expendable, operating from Mahia in New Zealand and Wallops in Virginia) and the in-development Neutron medium-lift rocket (~13 tonnes to LEO, reusable first stage, targeting first flight in H2 2026). The second is Space Systems — satellite buses (the Photon and Lightning platforms), subsystems (reaction wheels, star trackers, solar arrays, separation systems) and increasingly mission-management services. The two segments sell to each other and to external customers, which collapses inter-segment cost and supports a margin profile no pure launch company can match.

The mechanism that makes Rocket Lab structurally different is the vertical integration. Engines (Rutherford for Electron, Archimedes for Neutron — both designed and manufactured in-house), composite structures, avionics, software stack, and increasingly the optical-comms terminals (via the 2024 Mynaric acquisition) all come from inside the perimeter. SolAero gives them solar arrays, Sinclair Interplanetary the reaction wheels, Planetary Systems Corp the separation rings. This is the closest thing in public markets to a junior-SpaceX architectural blueprint.

Neutron is the binding economic asset for the next 24-36 months. It is designed for ~13 tonnes to LEO with first-stage reusability, sitting between Falcon 9 (~22 tonnes reusable) and the smaller-lift fleet. Strategically it is the only credible US alternative to Falcon 9 for medium-lift commercial and government missions — a category that ULA's Vulcan partially addresses but at higher cost per kilogram and without a real reusability story. The "hungry hippo" composite fairing is integrated with the first stage and reused with it (no $5-7M expendable fairing per flight), the payload envelope (~5m diameter × ~10m usable) is natively sized for mid-tier constellation deployment, and the nine-engine Archimedes cluster burns LOX/methane at ~1.5M lbf total thrust — the same propellant family as Raptor (Starship) and BE-4 (New Glenn / Vulcan).

Product roadmap

Electron: 50+ launches since first flight in 2017, ~99% success rate over the last several years, ~15-20 launches/year cadence target through 2026-2027. Neutron: first flight targeted H2 2026 from Wallops; multi-engine Archimedes static-fire campaign ongoing through Q2-Q3 2026; second-stage qualification in parallel. Designed for ~10-20 first-stage reuses. Photon spacecraft bus: flown on NASA's CAPSTONE lunar mission (2022), now baselined for SDA Tranche 2 Transport Layer deliveries via the Lightning bus variant (Rocket Lab is one of two awardees for 18 satellites valued at $515M total). Mynaric (acquired 2024): CONDOR Mk3 optical inter-satellite-link terminal, ~10 Gbps per link, ~1,500 km link range, $300-500K ASP — the OISL terminal is becoming mandatory across SDA Tranche 3 and commercial constellations.

What Rocket Lab doesn't make: no Starlink-equivalent satellite-broadband service; no heavy-lift vehicle beyond Neutron; no crewed-launch program; no GEO comsat buses (those go to LM and Northrop). The strategy is deliberately a small-and-mid launch + multi-vendor satellite-systems platform — the diversification is the moat.

The financial print

Per the May 7, 2026 Q1 print, Rocket Lab reported revenue of $123M (up ~30% YoY), with Space Systems contributing roughly 70% and Launch Services 30%. FY2025 closed at $480M revenue, up from $436M FY2024. Operating loss remains in the (-$200M) range driven by Neutron development capex (the program absorbs roughly $200M+ in annual R&D and capex). Sell-side coverage includes Citi, Cantor Fitzgerald, Morgan Stanley, B. Riley, Wells Fargo, Stifel, Bank of America, Deutsche Bank. Consensus FY2026 revenue is $620-720M; FY2027 stretches to $1.1-1.4B if Neutron commercial ramp materialises. Cash position post-Q1 was approximately $480M against a ~$50M quarterly burn — sufficient runway into late 2027 without a raise, though management has telegraphed willingness to opportunistically tap equity markets near highs.

The 1-year stock return through May 22, 2026 is approximately +196% (from ~$46 in May 2025 to $137.47 today). The Q2 2026 earnings drop in early August is the next binary — and by then the Neutron timeline will either be reconfirmed for H2 2026 launch or have begun slipping into 2027.

Customer mix today

In 2024, Space Systems was approximately 65% of revenue with Launch Services 35%, mostly small-lift Electron commercial customers. By 2026, the mix has flipped further toward government: per Q1 2026 disclosure and contract-backlog mapping, the breakdown is approximately SDA ~22%, NRO + NASA ~18%, Space Force / other DoD ~8% (combined US government ~48%), commercial constellation operators including BlackSky, HawkEye 360, Capella, Kineis at ~30%, and broader smallsat / academic / international government ~22%. The 2024-to-2026 shift is the SDA Tranche 2 contract execution layering government Space-Systems revenue on top of the existing Photon and components base — a multi-year recurring contribution that did not exist in 2023.

What's actually happening at the binding sub-segment — Neutron debut

The Neutron critical path through Q3 2026 is the entire equity story. Five gates: Archimedes engine qualification (multi-engine static fire — currently running, two-engine fire completed February 2026 per the Q4 2025 earnings call), first-stage structural qualification, second-stage qualification, Wallops launch-infrastructure commissioning, and FAA launch licensing. The May 7 earnings reconfirmed an H2 2026 maiden flight target but acknowledged "weeks of margin" not "months of margin" — read: any meaningful anomaly in the static-fire campaign pushes maiden launch into Q1 2027.

The downstream pipeline matters more than the maiden flight itself. The National Security Space Launch (NSSL) Phase 3 Lane 1 award pool, sized at $5.6B over the contract period, becomes accessible once Neutron flies successfully — Lane 1 (smaller, risk-tolerant missions) is the natural Rocket Lab entry point with award decisions expected through 2027-28. Lane 2 (high-assurance high-value) is reserved for ULA Vulcan and Falcon 9 / Falcon Heavy initially. Beyond NSSL, the Allied-constellation pipeline (Japan's WHITE program, EU's IRIS² consortium) is incremental optionality not in consensus.

The competitive threat / SpaceX, ULA, Relativity, Stoke

Direct competitive set in medium-lift: SpaceX Falcon 9 / Falcon Heavy (FY2025 launch-services revenue $5B+, ~95% commercial and government medium/heavy market share), ULA Vulcan (~$1B launch services revenue, NSSL Lane 2 dominant), Blue Origin New Glenn (early operational phase, low cadence), Relativity Space Terran R (in development on similar timeline to Neutron), Stoke Space (early development). In small-lift, the competitive field is essentially empty — Astra and Virgin Orbit are defunct, ABL has execution issues.

The bear-case competitive overhang is SpaceX pricing power. If Elon prices Falcon 9 reusable rideshare at $5-6K per kg (vs. Neutron's required $7-9K per kg to hit unit economics), commercial Neutron demand collapses to government-and-Allied launches only. No active IP litigation — the moat is operational (engine technology, vertical integration, flight heritage) rather than legal.

The terminal risk

The technology transition that obsoletes Neutron is Starship. If SpaceX achieves Starship commercial cadence at the targeted $10M-per-launch all-in cost with ~100-tonne payload, the medium-lift market structurally compresses — Neutron, Vulcan and New Glenn all become uncompetitive on $/kg. Consensus Starship commercial cadence is mid-2027 to 2028; the skeptic case is 2029-2030. If Starship hits the 2027 case, Rocket Lab's Neutron market is a 2027-2030 window before commoditisation. Named alternative players who would benefit: SpaceX directly, and possibly Stoke Space (full reusability architecture) at the longer horizon. Rocket Lab's credible response is the Space Systems segment scaling — the company has explicitly framed itself as a "diversified space prime" rather than a pure launch play, and that framing is what supports the valuation against the Starship terminal.

Bull / Gap / Optionality

Bull

1. Neutron first-launch in H2 2026 is the single largest near-term re-rate catalyst. Successful debut materially de-risks the medium-lift narrative and unlocks the $5.6B NSSL Phase 3 Lane 1 pipeline. Citi (April 2026 note) modelled a $20-30 stock impact from clean Neutron debut alone.

2. SDA Tranche 2 contract execution generates ~$515M revenue over the contract life per the 2024 award announcement — a multi-year recurring contribution that backs out near-term government Space Systems revenue and reduces dependence on Neutron commercial ramp.

3. Mynaric OISL terminal is the most under-appreciated leg. SDA Tranche 3 and Tranche 4 both require optical inter-satellite links, and CONDOR Mk3 is the only flight-qualified high-volume terminal in the western supply chain (China's optical comms players are excluded by ITAR). At $300-500K ASP and multi-thousand-unit demand visibility through 2028, this is a $400-600M revenue line by 2027 on its own.

4. Government space budget tailwind is durable. US Space Force budget grew from ~$26B in FY2024 to ~$30B+ guided for FY2026 per DoD budget submissions; the new administration's posture is incrementally MORE space-positive, not less. The defence-rotation-into-space-pure-plays trade we are observing in May 2026 is partly a result of capital flowing OUT of legacy primes (RTX, LMT both STRONG_EXIT on the same scan today).

5. Commercial-launch backlog for Neutron has begun to form. Management has hinted at multiple commercial customers for 2027 launches (Q4 2025 earnings call commentary). A formal commercial-backlog disclosure in 2026 — likely the Q3 print in November — would be a discrete catalyst above and beyond Neutron debut.

Gap

1. Equity is +37% vs 50MA at $137 — pure chase risk. RSI 69.3 puts the stock into the EXIT_WARN signal on our scanner. Historical Rocket Lab drawdown post-melt-up is severe — the December 2021 to December 2022 drawdown was -83% from $15 to $2.50; the November 2024 melt-up gave back -28% in three weeks. Buying $137 in May 2026 without sizing for a -15-20% mean-reversion is reckless.

2. Neutron first-launch slippage history in the space sector is severe. Vulcan slipped ~3 years; New Glenn slipped ~5 years; Ariane 6 slipped ~4 years; Starship has slipped multiple times. The base rate for "developmental rocket launches on initially-stated timeline" is approximately 20%. The May 7 reconfirm gave the equity a free-pass; the Q2 print in August will be the more honest test.

3. SpaceX competitive pricing on Falcon 9 is the silent overhang. Neutron's $/kg economics are aspirational at this point — first-stage reuse cadence of 10-20x is unproven, and SpaceX could match Neutron's effective per-kg pricing on commercial flights by simply not raising Falcon 9 prices.

4. FCF remains negative through 2026 and likely 2027. Cash position is comfortable now but the Neutron program capex through first commercial cadence is meaningfully back-loaded; any 12-month delay reopens the capital-raise question into a potentially weaker tape.

Optionality

The trade

Rocket Lab at $137.47 is the single best-in-class operator in this batch, but the equity sits +36.7% vs 50MA with RSI 69.3 — every quantitative signal says wait for a pullback. The honest framing is that Bucket-A names with cleaner technicals (PL, BKSY) get the first dollar; RKLB earns its B-bucket position by being the structural anchor of any Space portfolio you build over the next 24 months, not by being the cleanest entry today. Entry zone $130-$144 (current ±5%) — initiate 50bps starter if filled in zone, hold powder for a pullback to the 50-day moving average around $100 to scale a second tranche. Sizing 100bps total at full size, with the second tranche reserved for a $100-110 retest. Stop: close below the 34/50 EMA cloud, approximately $100 — that level coincides with the 50-day MA and the pre-melt-up consolidation, and a break there invalidates the Neutron-debut-priced-in thesis. Catalyst: Neutron maiden flight, H2 2026 (target September-December window). Pivot: if you want cleaner-expression of the same theme without the chase risk, PL (Planet Labs) is the lower-beta same-cycle play; if you want pure-launch leverage without the Rocket-Lab premium, FLY (Firefly) below is the smaller-cap catch-up.

Conviction: 8 / 10.

ticker: ASTS name: AST SpaceMobile, Inc. theme: Space Aerospace bucket: B conviction: 7 entryzonelo: 101.25 entryzonehi: 111.91 currentprice: 106.58 pricedate: 2026-05-22 positionsizepct: 0.75 stoploss: 83.43 thesisoneline: Direct-to-handset satellite cellular as MNO-partner infrastructure — either a $100bn regulatory monopoly or a capex incinerator. catalystnext: BlueBird-2 first-batch launch on Falcon 9 catalystdate: 2026-07-31 rsi: 68.3 vs50ma: 27.7 forwardpe: 0.0 themecycleposition: early customermixsummary: AT&T, Verizon, Vodafone, Rakuten, Telefonica, Orange — combined ~2.8bn addressable handsets; <5% of revenue today. terminalriskoneline: Direct-to-handset turns out to be a low-WTP feature, not a coverage-gap-killer — adoption stalls below 3% of post-paid subs. bulldriverscount: 5 gapriskscount: 4 optionalitycount: 6 lastearningsdate: 2026-05-13 nextearnings_date: 2026-08-12